Franks A J, Ellis E
Neuropathology Laboratory, Department of Pathology, University of Leeds, UK.
Br J Cancer. 1989 Mar;59(3):462-6. doi: 10.1038/bjc.1989.95.
The distribution of tissue plasminogen activator (t-PA) has been studied in a series of 38 human brain tumours and two specimens of cerebral cortex, using the monoclonal antibody ESP6. t-PA was localised in vascular endothelium in the majority of tumours and both the cortical specimens, confirmed by double staining with Ulex europaeus lectin (Uel) and Factor 8-related antigen. Nineteen out of 22 high grade astrocytomas showed strong endothelial staining whereas staining was weak or absent in the four low grade astrocytomas studied. No consistent relationship was found between the pattern of staining and tumour grade in the other tumours, although strong staining of the three metastatic lesions with Uel was observed. Among the astroglial tumours only one glioblastoma showed any tumour cell staining for t-PA, which raises questions concerning the origin of t-PA producing cells derived from human gliomas in vitro. Studies of t-PA in brain tumours should take account of this vascular localisation before concluding that the activity is derived from neoplastic cells.
使用单克隆抗体ESP6,在38例人脑肿瘤和两份大脑皮质标本中研究了组织型纤溶酶原激活剂(t-PA)的分布。t-PA定位于大多数肿瘤以及两份皮质标本的血管内皮中,这通过用欧洲荆豆凝集素(Uel)和因子8相关抗原进行双重染色得以证实。22例高级别星形细胞瘤中有19例显示出强烈的内皮染色,而在所研究的4例低级别星形细胞瘤中,染色较弱或无染色。在其他肿瘤中,尽管观察到三个转移病灶被Uel强烈染色,但未发现染色模式与肿瘤分级之间存在一致关系。在星形胶质细胞瘤中,只有一例胶质母细胞瘤显示出任何肿瘤细胞对t-PA的染色,这引发了关于体外源自人胶质瘤的t-PA产生细胞起源的问题。在得出该活性源自肿瘤细胞的结论之前,对脑肿瘤中t-PA的研究应考虑到这种血管定位。